Rebrote de parotiditis en la era vacunal. Factores implicados en un brote en Navarra, 2006–2007

Hilleman, 1967, Live attenuated mumps-virus vaccine. IV. Protective efficacy as measured in a field evaluation, N Engl J Med, 276, 252, 10.1056/NEJM196702022760502 Sugg, 1968, Field evaluation of live virus mumps vaccine, J Pediatr, 72, 461, 10.1016/S0022-3476(68)80334-8 2007, Comentario epidemiológico de las enfermedades de declaración obligatoria y Sistema de información microbiológica. Año 2006, Bol Epidemiol Semanal, 15, 109 Peltola, 2000, Mumps and rubella eliminated from Finland, JAMA, 284, 2643, 10.1001/jama.284.20.2643 1998, Measles, mumps, and rubella – vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mums: Recommendations of Advisory Committee on Immunization Practices (ACIP), Morb Mortal Wkly Rep, 47, 1 Ong, 2005, Comparative efficacy of Rubini, Jeryl-Lynn and Urabe mumps vaccine in an Asian population, J Infect, 51, 294, 10.1016/j.jinf.2004.10.001 Richard, 2003, Comparison of the effectiveness of two mumps vaccines during an outbreak in Switzerland in 1999 and 2000: A case-cohort study, Eur J Epidemiol, 18, 569, 10.1023/A:1024698900332 Pons, 2000, Two outbreaks of mumps in children vaccinated with the Rubini strain in Spain indicate low vaccine efficacy, Euro Surveill, 5, 80, 10.2807/esm.05.07.00014-en Savage, 2005, BMJ, 330, 1119, 10.1136/bmj.330.7500.1119 Sartorius, 2005, An outbreak of mumps in Sweden, February–April 2004, Euro Surveill, 10, 191, 10.2807/esm.10.09.00559-en Dayan, 2008, Recent resurgence of mumps in the United States, N Engl J Med, 358, 1580, 10.1056/NEJMoa0706589 2008 Reina, 2003, Comparison between indirect immunofluorescence assay and shell vial culture for detection of mumps virus from clinical samples, J Clin Microbiol, 41, 5186, 10.1128/JCM.41.11.5186-5187.2003 2001 Gerstel L, Lenglet A, García Cenoz M. Mumps outbreak in young adults following a village festival in the Navarra region, Spain, August 2006. Euro Surveill [revista electrónica] 2006;11:E061109.4. [consultado 08/09/2008] Disponible en: http://www.eurosurveillance.org/ew/2006/061109.asp#4 Sanz, 2008, Evolución de los casos de parotiditis confirmados serológicamente en la Comunidad de Madrid durante un período de 7 años (2000–2006), Med Clin (Barc), 130, 292, 10.1157/13116573 Cohen, 2007, Vaccine effectiveness estimates, 2004–2005 mumps outbreak, England, Emerg Infect Dis, 13, 12, 10.3201/eid1301.060649 Nöjd, 2001, Mumps virus neutralizing antibodies do no protect against reinfection with a heterologous mumps virus genotype, Vaccine, 19, 1727, 10.1016/S0264-410X(00)00392-3 Hviid, 2008, Mumps, Lancet, 371, 932, 10.1016/S0140-6736(08)60419-5 Plotkin SA. Mumps vaccine. En: Plotkin SA, Orenstein WA, editores. Vaccines (4th ed.), Philadelphia: WB Saunders; 2004. p. 452.